within Pharmacolibrary.Drugs.ATC.B;

model B03BA51
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.02,
    Cl             = 0.13333333333333333,
    adminDuration  = 600,
    adminMass      = 0.1,
    adminCount     = 1,
    Vd             = 0.004,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0013333333333333333,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Cyanocobalamin, commonly known as vitamin B12, is an essential water-soluble vitamin that is used to treat and prevent vitamin B12 deficiency. It is crucial for normal functioning of the brain, nerves, and blood cells. In combinations (ATC: B03BA51), it may be co-formulated with other nutrients (often with folic acid or other B vitamins) for treatment of various anemias and deficiencies. Cyanocobalamin is still approved and widely used as both a therapeutic agent and dietary supplement.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters are estimated for healthy adult individuals, as no specific published references for combination products are available.</p><h4>References</h4><ol><li><p>Thakkar, K, &amp; Billa, G (2015). Treatment of vitamin B12 deficiency-methylcobalamine? Cyancobalamine? Hydroxocobalamin?-clearing the confusion. <i>European journal of clinical nutrition</i> 69(1) 1–2. DOI:<a href=&quot;https://doi.org/10.1038/ejcn.2014.165&quot;>10.1038/ejcn.2014.165</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/25117994/&quot;>https://pubmed.ncbi.nlm.nih.gov/25117994</a></p></li><li><p>Kumar, N, et al., &amp; Ahlskog, JE (2004). Copper deficiency myelopathy produces a clinical picture like subacute combined degeneration. <i>Neurology</i> 63(1) 33–39. DOI:<a href=&quot;https://doi.org/10.1212/01.wnl.0000132644.52613.fa&quot;>10.1212/01.wnl.0000132644.52613.fa</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/15249607/&quot;>https://pubmed.ncbi.nlm.nih.gov/15249607</a></p></li><li><p>Bhowmik, M, et al., &amp; R, R (2025). Cyanocobalamin-loaded dissolving microneedles for enhanced transdermal delivery: development, characterization, and pharmacokinetic evaluation. <i>Biomedical microdevices</i> 27(2) 20–None. DOI:<a href=&quot;https://doi.org/10.1007/s10544-025-00747-0&quot;>10.1007/s10544-025-00747-0</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/40310523/&quot;>https://pubmed.ncbi.nlm.nih.gov/40310523</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end B03BA51;
